Emerging Infectious Diseases

Papers
(The H4-Index of Emerging Infectious Diseases is 85. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 500 papers]. The publications cover those that have been published in the past four years, i.e., from 2019-09-01 to 2023-09-01.)
ArticleCitations
Severe Acute Respiratory Syndrome Coronavirus 2−Specific Antibody Responses in Coronavirus Disease Patients1236
High Contagiousness and Rapid Spread of Severe Acute Respiratory Syndrome Coronavirus 21087
Aerosol and Surface Distribution of Severe Acute Respiratory Syndrome Coronavirus 2 in Hospital Wards, Wuhan, China, 2020724
COVID-19 Outbreak Associated with Air Conditioning in Restaurant, Guangzhou, China, 2020620
Serial Interval of COVID-19 among Publicly Reported Confirmed Cases466
Severe Acute Respiratory Syndrome Coronavirus 2 from Patient with Coronavirus Disease, United States448
US CDC Real-Time Reverse Transcription PCR Panel for Detection of Severe Acute Respiratory Syndrome Coronavirus 2432
Community Transmission of Severe Acute Respiratory Syndrome Coronavirus 2, Shenzhen, China, 2020410
Nonpharmaceutical Measures for Pandemic Influenza in Nonhealthcare Settings—Social Distancing Measures407
Infectious SARS-CoV-2 in Feces of Patient with Severe COVID-19389
Coronavirus Disease Outbreak in Call Center, South Korea375
Indirect Virus Transmission in Cluster of COVID-19 Cases, Wenzhou, China, 2020375
Evidence Supporting Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 While Presymptomatic or Asymptomatic372
Contact Tracing during Coronavirus Disease Outbreak, South Korea, 2020366
Potential Presymptomatic Transmission of SARS-CoV-2, Zhejiang Province, China, 2020353
Detection of Novel Coronavirus by RT-PCR in Stool Specimen from Asymptomatic Child, China353
Public Mental Health Crisis during COVID-19 Pandemic, China342
Evaluating the Effectiveness of Social Distancing Interventions to Delay or Flatten the Epidemic Curve of Coronavirus Disease300
Pathology and Pathogenesis of SARS-CoV-2 Associated with Fatal Coronavirus Disease, United States289
Risk for Transportation of Coronavirus Disease from Wuhan to Other Cities in China281
Community Responses during Early Phase of COVID-19 Epidemic, Hong Kong270
Multicenter Epidemiologic Study of Coronavirus Disease–Associated Mucormycosis, India259
Inactivation of Severe Acute Respiratory Syndrome Coronavirus 2 by WHO-Recommended Hand Rub Formulations and Alcohols254
Human-to-Human Transmission of Monkeypox Virus, United Kingdom, October 2018247
Co-infection with SARS-CoV-2 and Influenza A Virus in Patient with Pneumonia, China239
Rhabdomyolysis as Potential Late Complication Associated with COVID-19239
Case-Fatality Risk Estimates for COVID-19 Calculated by Using a Lag Time for Fatality228
Estimating the Frequency of Lyme Disease Diagnoses, United States, 2010–2018226
Persistence of Severe Acute Respiratory Syndrome Coronavirus 2 in Aerosol Suspensions226
Lack of Vertical Transmission of Severe Acute Respiratory Syndrome Coronavirus 2, China224
Potential Fifth Clade ofCandida auris,Iran, 2018215
Possible Bat Origin of Severe Acute Respiratory Syndrome Coronavirus 2206
Identifying and Interrupting Superspreading Events—Implications for Control of Severe Acute Respiratory Syndrome Coronavirus 2204
Decreased Influenza Incidence under COVID-19 Control Measures, Singapore203
SARS-CoV-2 Transmission between Mink (Neovison vison) and Humans, Denmark196
SARS-CoV-2 Virus Culture and Subgenomic RNA for Respiratory Specimens from Patients with Mild Coronavirus Disease188
Multidrug-Resistant Candida auris Infections in Critically Ill Coronavirus Disease Patients, India, April–July 2020185
Cluster of Coronavirus Disease Associated with Fitness Dance Classes, South Korea184
Clusters of Coronavirus Disease in Communities, Japan, January–April 2020171
Imported Monkeypox, Singapore165
Genomic Evidence of SARS-CoV-2 Reinfection Involving E484K Spike Mutation, Brazil158
Effectiveness of N95 Respirator Decontamination and Reuse against SARS-CoV-2 Virus156
COVID-19–Associated Pulmonary Aspergillosis, March–August 2020151
Prolonged Infectivity of SARS-CoV-2 in Fomites150
Viral RNA Load in Mildly Symptomatic and Asymptomatic Children with COVID-19, Seoul, South Korea149
Nonpharmaceutical Measures for Pandemic Influenza in Nonhealthcare Settings—Personal Protective and Environmental Measures146
Middle East Respiratory Syndrome Coronavirus Transmission146
Transmission of SARS-CoV 2 During Long-Haul Flight143
Asymptomatic and Human-to-Human Transmission of SARS-CoV-2 in a 2-Family Cluster, Xuzhou, China141
Estimating Risk for Death from Coronavirus Disease, China, January–February 2020141
Severe Acute Respiratory Syndrome Coronavirus 2 RNA Detected in Blood Donations139
Monitoring SARS-CoV-2 Circulation and Diversity through Community Wastewater Sequencing, the Netherlands and Belgium139
Case-Control Study of Use of Personal Protective Measures and Risk for SARS-CoV 2 Infection, Thailand137
Intrafamilial Exposure to SARS-CoV-2 Associated with Cellular Immune Response without Seroconversion, France137
Novel SARS-CoV-2 Variant in Travelers from Brazil to Japan132
Prolonged Persistence of SARS-CoV-2 RNA in Body Fluids129
Encephalopathy and Encephalitis Associated with Cerebrospinal Fluid Cytokine Alterations and Coronavirus Disease, Atlanta, Georgia, USA, 2020128
Probable Transmission of SARS-CoV-2 Omicron Variant in Quarantine Hotel, Hong Kong, China, November 2021127
SARS-CoV-2 in Quarantined Domestic Cats from COVID-19 Households or Close Contacts, Hong Kong, China126
Imported Monkeypox from International Traveler, Maryland, USA, 2021124
SARS-CoV-2 Natural Transmission from Human to Cat, Belgium, March 2020124
Aspergillosis Complicating Severe Coronavirus Disease123
Effect of Environmental Conditions on SARS-CoV-2 Stability in Human Nasal Mucus and Sputum122
Experimental Infection of Cattle with SARS-CoV-2121
Estimate of Burden and Direct Healthcare Cost of Infectious Waterborne Disease in the United States121
Susceptibility of Raccoon Dogs for Experimental SARS-CoV-2 Infection119
Rapid, Sensitive, Full-Genome Sequencing of Severe Acute Respiratory Syndrome Coronavirus 2113
Policy Decisions and Use of Information Technology to Fight Coronavirus Disease, Taiwan112
Reemergence of Human Monkeypox and Declining Population Immunity in the Context of Urbanization, Nigeria, 2017–2020109
Isolation, Sequence, Infectivity, and Replication Kinetics of Severe Acute Respiratory Syndrome Coronavirus 2108
Clinicopathologic and Immunohistochemical Findings from Autopsy of Patient with COVID-19, Japan108
Culture-Competent SARS-CoV-2 in Nasopharynx of Symptomatic Neonates, Children, and Adolescents107
Worldwide Effects of Coronavirus Disease Pandemic on Tuberculosis Services, January–April 2020104
Fatal Invasive Aspergillosis and Coronavirus Disease in an Immunocompetent Patient104
Detection and Characterization of Bat Sarbecovirus Phylogenetically Related to SARS-CoV-2, Japan103
Resurgence of Respiratory Syncytial Virus Infections during COVID-19 Pandemic, Tokyo, Japan100
Triplex Real-Time RT-PCR for Severe Acute Respiratory Syndrome Coronavirus 298
Novel Subclone of Carbapenem-Resistant Klebsiella pneumoniae Sequence Type 11 with Enhanced Virulence and Transmissibility, China98
Collateral Benefit of COVID-19 Control Measures on Influenza Activity, Taiwan95
Epidemiologic Evidence for Airborne Transmission of SARS-CoV-2 during Church Singing, Australia, 202092
Waning Antibody Responses in Asymptomatic and Symptomatic SARS-CoV-2 Infection92
Antibody Responses 8 Months after Asymptomatic or Mild SARS-CoV-2 Infection91
Epidemiology of Coronavirus Disease in Gansu Province, China, 202088
Coronavirus Disease among Workers in Food Processing, Food Manufacturing, and Agriculture Workplaces87
Prognostic Value of Leukocytosis and Lymphopenia for Coronavirus Disease Severity86
Population-Based Estimates of Chronic Conditions Affecting Risk for Complications from Coronavirus Disease, United States85
Detection of Severe Acute Respiratory Syndrome Coronavirus 2 RNA on Surfaces in Quarantine Rooms85
0.019261121749878